- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03488095
Behavior Changing Intervention for Smokeless Tobacco and Betel Quid Use in Adolescents
Behavior Changing Intervention for Smokeless Tobacco and Betel Quid Use in Adolescents: A Cluster-Randomized Trial
Smokeless tobacco (SLT) is a known risk factor for Oral, Pharyngeal and Esophageal carcinoma. Three-quarters global SLT consumption is among the South Asian Population. The habit of SLT chewing commences at a very young age which has an underpinning of socio-cultural dimension in South Asian population which perhaps due to its more addictive potential, has more dependency. Youth also perceives SLT as a part of confectionery, which is socially served in South Asian ceremonies. There exists very little or no evidence regarding efficacy of SLT cessation interventions in this population. Most of the existing interventions are based in western world with little or no cultural sensitivities pertinent to South Asia. In this study, a culturally rooted behavior changing intervention (BCI) to alter SLT use prevalence, perceptions pertinent to the deleterious effects of SLT use in the etiology of oral cancers and help youth quit SLT in Karachi, Pakistan.
Baseline demography and SLT use prevalence will be ascertained among 11-16-year-old school going children from both government and private schools. Multi stage cluster sampling will randomly recruit forty clusters (schools) from within 6 districts of Karachi, which will then be divided into intervention and control groups (clusters) using block randomization based on proportionate number of each school type present (Government and Private).
Both groups' participants will complete all questionnaires pre and post intervention as described elsewhere and will also undergo screening for oral cancer and oral potentially malignant lesions (OPMLs). Students in intervention cluster will be given BCI and printed pamphlets along with a gift pack (reminder for SLT quit, a branded tooth paste and a tooth brush) while students in control cluster will only differ in that they will not be exposed to BCI.
BCI was designed after reviewing literature and consulting specialist group for all untoward effects of SLT use in Oral Cavity that have a potential of transforming into oral carcinoma.
A follow up after 12 weeks will be conducted to re-assess their SLT use prevalence, perceptions regarding hazardous effects of SLT use in oral cavity, dependency on SLT and success in quit (among users in both groups), and perception regarding warning labels on SLT product packet
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
In lieu of the increasing disease burden of oral cancer in South Asian countries due to increasing popularly fashionable SLT consumption; the objective is to develop (i) a BCI pertinent to socio-cultural aspect for South Asian SLT users, followed by (ii) assessing its efficacy in changing perception and dependency regarding SLT use in high risk group of 11-16 years old school going children of Karachi of both private and public sector schools.
It is also aimed to deconstruct the BCI to establish which components of our BCT are more useful in making an intervention most efficient by using sub-indices of fidelity index to assess the adherence and quality of each component of intervention. Each component will be scored using fidelity index by a neutral trained listener each time intervention is delivered by a trained personnel.
Quantitatively, the objectives of the study are to:
i. measure SLT/ or BQ use prevalence amongst adolescents of 11-16 years ii. assess the reasons behind their use of SLT/ or BQ in users (both intervention and control clusters) by using Reasons for Betel Quid Chewing Scale (RBCS).
iii. evaluate the dependency on SLT/ or BQ in users (both intervention and control clusters) using Fagerstörm Tobacco and Nicotine Dependency scale for Smokeless Tobacco (FTND-ST) and Betel Quid Dependency by using Betel Quid Dependency Scale (BQDS).
iv. assess perceptions of adolescents (both intervention and control clusters) regarding ill effects of SLT/ or BQ use in oral cavity causing oral cancer and OPMLs.
v. assess the perception of adolescents regarding oral cancer picture of SLT/ or BQ product pack in cessation of its use with the help of Behavior Changing Intervention in intervention cluster and a questionnaire item in control cluster.
vi. evaluate each component of Behavior Changing Intervention in its efficacy by using fidelity index and self-perceived efficacy by participants of intervention cluster.
This study will be conducted at government and private schools of Karachi as schools have the maximum probability of engaging focused age group of mixed ethnicity, religion, different cultures and different socio-economic strata of the population. Also, these young individuals spend a substantial number of their waking hours in school thus they are easily approachable globally without needing to delineate or be reliant on families(41).
With a population of approximately 24 million, Karachi is the largest city of Pakistan(42). Karachi City government has divided the city into six (6) districts in 2013 with each district being further divided into administrative towns of total 18 in number(43).
Multi stage cluster sampling will be done. Out of six districts, 26 clusters (secondary schools) will be randomly selected proportionate to the number of each school type (ensuring equal participation of government and private schools). The students of 11-16 years of age, studying in grade VI - Grade X will be randomly recruited. Complete lists of all private and government schools of Karachi have been arranged by requesting respective Directors (Appendix 6). If any randomly selected school declines to participate than another school will be randomly selected from the same district; also, a government school will be selected if government school will decline and vice versa. Fifty-100 students per school will be randomly included in the study. Depending upon the size of each class, students will be randomly selected from each of the secondary classes present on the day of our visit till a total number of 50-100 is reached.
This will therefore summit a total sample size of 2200 that may be considered representative of the 11-16 year adolescents of Karachi as Global Youth Tobacco Survey conducted in Karachi, Pakistan in 2008 enrolled 720 individuals of 13-15 years for comprehensive tobacco control program(44).
Students of younger or older age group than mentioned already will be excluded and students who already are undergoing treatments for Oral Cancer will be excluded.
For recruitment purposes, investigators will contact principals of selected schools (both government and private) to provide them with details regarding the intervention, its merits and efficacy, and will request for their inclination to participate in the trial. If any selected school refuses to participate then another school of same profile will be sent an invitation.
Schools' heads will then be requested to send consent forms (will be provide to schools) to the parents along with a covering letter in which they will be provided with all relevant details regarding intervention and will be encouraged to contact principal investigator via a text on given contact number who will then call parents to respond to all queries since principal investigator does not have toll-free number(33).
Parents will be requested to sign an acceptance or refusal on the form and sent it back to school by a specific decided date.
After 12 weeks, a follow up visit will ensue to:
- Re-assess their perceptions regarding SLT/or BQ use in users and non-users of both intervention and control clusters.
- Re-assess their dependency on SLT/or BQ in users of both intervention and control clusters.
- Re-evaluate their perceptions (of users and non-users of intervention cluster) regarding warning labels on SLT/or BQ product packet
- Collect their quit calendars to assess quit from users of both intervention and control clusters, and
- Collect perceived efficacy of each component of BCI that helped them quit, attempt to quit or change perceptions from all users and non-users of intervention cluster to assess efficacy of each component of BCI.
Any differences in outcome based on BCI will be assessed and documented between two arms of cluster-randomized trial.
The change in perceptions if at all, after four weeks, regarding imprinting of pictorial warning labels on SLT packaging will help us in recommending its implementation at National level to curb SLT use.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Sind
-
Karachi, Sind, Pakistan, 75280
- Dow University of Health Sciences
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
• 11-16 years school going children with NO diagnosed oral cancer
Exclusion Criteria:
- Students younger or older than mentioned ages
- Diagnosed Oral Cancer patients
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
OTHER: Behavior changing intervention
Thirty minutes behavior counselling (PPT.) to experimental group.
BCI for SLT and BQ Use in Adolescents: A CRT
|
BCI for SLT and BQ Use in Adolescents: A CRT is aimed towards changing Adolescenst behaviors regarding their SLT and BQ use to as to reduce Oral cancer Burden within population because of this.
|
|
NO_INTERVENTION: Control Cluster
No thirty minutes behavior counselling (PPT.) to control group
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changing perceptions regarding SLT and BQ use
Time Frame: 3 months
|
modified Global Youth Tobacco Survey will be used to assess the perceptions of adolescents
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
prevalence of SLT and BQ use in 11-16-year-old
Time Frame: 3 months
|
modified Global Youth Tobacco Survey will be used
|
3 months
|
|
Quit/quit attempts by the participants
Time Frame: three months
|
modified Global Youth Tobacco Survey will be used
|
three months
|
|
prevalence of OPMLs in the users of SLT and BQ
Time Frame: three months
|
modified Global Youth Tobacco Survey will be used
|
three months
|
|
perceptions regarding warning labels on SLT and BQ product pack
Time Frame: three months
|
modified Global Youth Tobacco Survey will be used
|
three months
|
Collaborators and Investigators
Investigators
- Study Chair: Kashif Sahfique, PhD, Dow University of Health Sciences
Publications and helpful links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- DUHS/DR-O/2016/116
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- SAP
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Oral Cavity Carcinoma
-
Ohio State University Comprehensive Cancer CenterRecruitingTongue Cancer | Recurrent Squamous Cell Carcinoma of the Hypopharynx | Recurrent Squamous Cell Carcinoma of the Larynx | Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity | Recurrent Verrucous Carcinoma of the Larynx | Recurrent Verrucous Carcinoma of the Oral Cavity | Recurrent Adenoid... and other conditionsUnited States
-
University of WashingtonBlaze Bioscience Inc.TerminatedStage III Lip and Oral Cavity Cancer AJCC v8 | Oral Cavity Squamous Cell Carcinoma | Stage I Lip and Oral Cavity Cancer AJCC v8 | Stage II Lip and Oral Cavity Cancer AJCC v8 | Stage IVA Lip and Oral Cavity Cancer AJCC v8United States
-
Ohio State University Comprehensive Cancer CenterCompletedTongue Cancer | Lip and Oral Cavity Squamous Cell Carcinoma | Oral Cavity Verrucous Carcinoma | Stage 0 Lip and Oral Cavity CancerUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)WithdrawnRecurrent Squamous Cell Carcinoma of the Lip and Oral Cavity | Recurrent Squamous Cell Carcinoma of the Oropharynx | Recurrent Verrucous Carcinoma of the Oral Cavity | Stage I Squamous Cell Carcinoma of the Lip and Oral Cavity | Stage I Squamous Cell Carcinoma of the Oropharynx | Stage I Verrucous... and other conditionsUnited States
-
University of Michigan Rogel Cancer CenterRecruitingStage III Lip and Oral Cavity Cancer AJCC v8 | Oral Cavity Squamous Cell Carcinoma | Stage I Lip and Oral Cavity Cancer AJCC v8 | Stage II Lip and Oral Cavity Cancer AJCC v8 | Stage IVA Lip and Oral Cavity Cancer AJCC v8United States
-
Wake Forest University Health SciencesTerminatedStage I Adenoid Cystic Carcinoma of the Oral Cavity | Stage I Mucoepidermoid Carcinoma of the Oral Cavity | Stage I Squamous Cell Carcinoma of the Hypopharynx | Stage I Squamous Cell Carcinoma of the Larynx | Stage I Squamous Cell Carcinoma of the Lip and Oral Cavity | Stage I Verrucous Carcinoma... and other conditionsUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyWithdrawnTongue Cancer | Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity | Stage III Verrucous Carcinoma of the Oral Cavity | Stage IVA Verrucous Carcinoma of the Oral Cavity | Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity | Stage IVB Verrucous Carcinoma of the Oral Cavity | Stage IVA Squamous Cell Carcinoma of the Lip and Oral CavityUnited States
-
Ohio State University Comprehensive Cancer CenterCompletedTongue Cancer | Stage I Squamous Cell Carcinoma of the Lip and Oral Cavity | Stage I Squamous Cell Carcinoma of the Oropharynx | Stage I Verrucous Carcinoma of the Oral Cavity | Stage II Squamous Cell Carcinoma of the Lip and Oral Cavity | Stage II Squamous Cell Carcinoma of the Oropharynx | Stage... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Hypopharyngeal Squamous Cell Carcinoma | Recurrent Laryngeal Squamous Cell Carcinoma | Recurrent Oropharyngeal Squamous Cell Carcinoma | Recurrent Lip and Oral Cavity Squamous Cell Carcinoma | Recurrent Laryngeal Verrucous Carcinoma | Recurrent Oral Cavity Verrucous Carcinoma | Tongue... and other conditionsUnited States
-
University of ChicagoNational Cancer Institute (NCI)CompletedPrecancerous Condition | Lip and Oral Cavity Squamous Cell Carcinoma | Oral Cavity Verrucous CarcinomaUnited States
Clinical Trials on BCI for SLT and BQ Use in Adolescents: A CRT
-
Akdeniz UniversityCompletedInternet Addiction | Problematic Internet Use | Healthy Internet UseTurkey (Türkiye)
-
University of South FloridaUniversity of MiamiUnknownMisophoniaUnited States
-
Region SkaneLund UniversityRecruitingAdolescent Behavior | Family Relations | Social Media Addiction | Gaming DisorderSweden
-
Azienda USL ModenaCompleted
-
HIV Prevention Trials NetworkNational Institute of Allergy and Infectious Diseases (NIAID); Division of...CompletedHIV Infection | Sexually Transmitted Infections | Pre-exposure Prophylaxis | Systems NavigationMalawi
-
HIV Prevention Trials NetworkNational Institute on Drug Abuse (NIDA); National Institute of Allergy and...CompletedHIV Infections | Opioid Use | Drug Use | Opioid-use DisorderUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLocalized Resectable Neuroblastoma | Localized Unresectable Neuroblastoma | Regional Neuroblastoma | Stage 4S Neuroblastoma | Ganglioneuroblastoma | Stage 4 NeuroblastomaUnited States